Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / July / Tracking Ebolas Next Move
Clinical care Screening and monitoring Infectious Disease

Tracking Ebola's Next Move

As cases continue to rise in the Democratic Republic of the Congo and Uganda, David Schwartz discusses diagnostics, surveillance, and outbreak preparedness

By Jessica Allerton 07/16/2026 Discussion 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Poll
  • Top Institutions

Share

Clinical Report: Tracking Ebola's Next Move

Background

Ebola virus disease remains a significant public health concern due to its high mortality rate and the complexities involved in early diagnosis. The overlap of symptoms with other endemic diseases complicates the identification of Ebola, especially in outbreak settings with limited healthcare infrastructure.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Ebola virus disease symptoms are nonspecific in early stages, resembling other illnesses.
  • RT-PCR is the gold-standard diagnostic test but requires specialized infrastructure.
  • Antigen-based tests are less sensitive than PCR, particularly in early disease stages.
  • Logistical challenges include sample handling and PPE shortages, impacting diagnosis and infection control.
  • The current outbreak in Ituri Province faces unique challenges due to ongoing conflict and population movement.

Clinical Implications

Healthcare professionals must be aware of the diagnostic limitations during Ebola outbreaks.

Conclusion

Addressing the diagnostic challenges of Ebola virus disease is critical for managing outbreaks.

Related Resources & Content

  1. WHO, Disease Outbreak News, 2026 -- Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda
  2. WHO, 2026 -- Guidelines for the clinical management of filovirus disease
  3. Stat News — What Ebola and Marburg are teaching us about the next pandemic
  4. Stat News — What if this Ebola outbreak can’t be stopped?
  5. Stat News — I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action
  6. Stat News — First hantavirus, now Ebola: What two outbreaks reveal about global preparedness
  7. What Ebola and Marburg are teaching us about the next pandemic
  8. What if this Ebola outbreak can’t be stopped?
  9. I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action
  10. First hantavirus, now Ebola: What two outbreaks reveal about global preparedness
  11. Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda
  12. WHO guidelines for the clinical management of filovirus disease

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.